Population‐Specific HLA Profiles in Generalised Pustular Psoriasis in Sarawak, Malaysia
Experimental Dermatology · 2026-05 · 35 (5)
DOI: 10.1111/exd.70258 ↗At a glance
Multizentrische Studie in Experimental Dermatology, published online on 2026-04-29. Written by Ingrid Pao Lin Ting and 6 co-authors. Institution: Department of Dermatology, Sarawak General Hospital, Sarawak, Ministry of Health Malaysia, Kuching, Malaysia. Major MEDLINE topics: Psoriasis, HLA Antigens. 48 references. Funded by: Ministry of Health.
Abstract (original language)
Genetic studies mutations (IL36RN, CARD14 and AP1S3) account for only 28.6% of generalised pustular psoriasis (GPP) leaving much of its pathogenesis remained to be elucidated. Emerging evidence suggests Th17–mediated inflammation, potentially driven by specific HLA class alleles, may underlie dysregulated IL‐36 signalling. This study explores the genotypic and phenotypic features of autochthonous GPP in Sarawak. A cross‐sectional case–control study was conducted in Sarawak's three main dermatology centres. GPP patients ( n = 43) fulfilling ERASPEN criteria between 1997 and June 2024 were included (23 with GPP alone); 20 with concomitant psoriasis vulgaris. HLA genotyping (HLA‐A, ‐B, ‐C, ‐DR) was performed via polymerase chain reaction and sequence‐specific oligonucleotide probe hybridisation (PCR‐SSO) methods at the Institute of Medical Research (IMR). HLA frequencies were compared to 90 Sarawakian controls from Malaysian Stem Cell Registry. Female predominance was noted (1:4.4). Median age at GPP onset was 29 years. Family history of psoriasis was reported in 30.2%, with 16% females developing GPP during pregnancy. Treatment responses: corticosteroids (100%), ciclosporin (82.1%), acitretin (60%) and methotrexate (50%). While biologics were effective in 10 patients. Common alleles included HLA‐DRB1*12:02, HLA‐A*11:01 and HLA‐C*07:02 while HLA‐C06:02 was not observed. HLA‐A*02:07 and HLA‐B*46:01 were observed only in concomitant psoriasis patients. HLA‐A*11:02 was seen in patients with ciclosporin non‐response, HLA‐A*24:02 in those with poorer responses to acitretin and methotrexate and HLA‐B*38:02 in psoriatic arthritis. Lower frequencies of HLA‐B*35:05 and HLA‐C*04:01 were observed among Dayak patients. The absence of HLA‐C*06:02 and variation in allele frequencies in this cohort may reflect population‐specific patterns but require validation in larger studies.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Dermatology, Sarawak General Hospital, Sarawak, Ministry of Health Malaysia, Kuching, Malaysia.
- Dermatology Unit, Miri Hospital, Sarawak, Ministry of Health Malaysia, Miri, Malaysia.
- Dermatology Unit, Sibu Hospital, Sarawak, Ministry of Health Malaysia, Sibu, Malaysia.
- Transplantation Immunology Unit, Allergy and Immunology Research Centre (AIRC), Institute for Medical Research, National Institutes of Health, Selangor, Malaysia.
ORCID profiles: Ingrid Pao Lin Ting, Hock Gin Teo, Min Moon Tang
Funding
- Ministry of Health
Cite
APA
Ting, I. P. L., Teo, H. G., Koay, B. T., Khairul-Fahmy, N., Arip, M., Mustafa, N., & Tang, M. M. (2026). Population‐Specific HLA Profiles in Generalised Pustular Psoriasis in Sarawak, Malaysia. Experimental Dermatology, 35(5). https://doi.org/10.1111/exd.70258
Vancouver
Ting IPL, Teo HG, Koay BT, Khairul-Fahmy N, Arip M, Mustafa N, et al. Population‐Specific HLA Profiles in Generalised Pustular Psoriasis in Sarawak, Malaysia. Experimental Dermatology. 2026;35(5). doi:10.1111/exd.70258
BibTeX
@article{Ting2026,
author = {Ting, Ingrid Pao Lin and Teo, Hock Gin and Koay, Bee Tee and Khairul-Fahmy, Norfarhana and Arip, Masita and Mustafa, Norhazlin and Tang, Min Moon},
title = {Population‐Specific HLA Profiles in Generalised Pustular Psoriasis in Sarawak, Malaysia},
journal = {Experimental Dermatology},
year = {2026},
volume = {35},
number = {5},
doi = {10.1111/exd.70258}
}
EUVIMED